These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25546109)

  • 1. Plasma homocysteine level in patients with Behçet's disease.
    Balta I; Balta S; Ozturk C; Demirkol S
    Int J Rheum Dis; 2015 Jun; 18(5):582. PubMed ID: 25546109
    [No Abstract]   [Full Text] [Related]  

  • 2. The relation between serum homocysteine level and eye involvement in Behçet's disease.
    Aflaki E; Mehryar M; Nazarinia MA; Habibagahi Z; Rajaee A; Ranjbar-Omrani G
    Arch Iran Med; 2008 Nov; 11(6):625-8. PubMed ID: 18976033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
    Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
    Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of prothrombotic risk in patients with Behçet's disease should include homocysteine plasma levels.
    Danese S; Papa A; Gasbarrini G; Gasbarrini A
    J Rheumatol; 2001 Dec; 28(12):2764-5. PubMed ID: 11764237
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis.
    Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F
    Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
    Messedi M; Frigui M; Chaabouni Kh; Turki M; Neifer M; Lahiyani A; Messaouad M; Bahloul Z; Ayedi F; Jamoussi K
    Gene; 2013 Sep; 527(1):306-10. PubMed ID: 23827456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of Behçet's disease; status of Behçet's disease in Japan].
    Shimizu T; Inaba G
    Ryumachi; 1976 May; 16(2):224-33. PubMed ID: 959908
    [No Abstract]   [Full Text] [Related]  

  • 9. A unique case of thrombosis in Behçet's disease with methylene tetrahydrofolate reductase homozygous polymorphism and raised homocysteine levels.
    Vasudevan B; Verma R; Pragasam V; Malik A; Venugopal R; Gopal M
    Indian J Dermatol Venereol Leprol; 2013; 79(4):531-3. PubMed ID: 23760328
    [No Abstract]   [Full Text] [Related]  

  • 10. The association between vitamin D level and Behcet's disease: a meta-analysis.
    Pitukweerakul S; Sinyagovskiy P; Prachuapthunyachart S
    Int J Rheum Dis; 2017 Dec; 20(12):2217-2218. PubMed ID: 28608505
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of age and sex on Behçet's disease.
    Bardak Y
    J Rheumatol; 1999 Apr; 26(4):1008-9. PubMed ID: 10229439
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma homocysteine level and uveitis in Behçet's disease.
    Okka M; Oztürk M; Kockar MC; Bavbek N; Rasier Y; Gunduz K
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):931-4. PubMed ID: 12455183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behçet's disease].
    Fujino Y
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():381-8. PubMed ID: 11838143
    [No Abstract]   [Full Text] [Related]  

  • 14. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
    Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
    J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behçet's syndrome in Korea: a look at the clinical picture.
    Kim HJ; Bang D; Lee SH; Yang DS; Kim DH; Lee KH; Lee S; Kim HB; Hong WP
    Yonsei Med J; 1988; 29(1):72-8. PubMed ID: 3381549
    [No Abstract]   [Full Text] [Related]  

  • 16. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prognosis on Behcet's disease under long period of observation].
    Imai Y
    Nippon Ganka Gakkai Zasshi; 1970 Sep; 74(9):1118-20. PubMed ID: 5528715
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiology and the present status of Behcet's syndrome].
    Araki Y
    Saishin Igaku; 1971 Mar; 26(3):458-64. PubMed ID: 5547388
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
    Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
    Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.